New study links GLP-1 use to reduced alcohol consumption
New research from consultancy KAM, in partnership with the Drinkaware charity, has highlighted a -29% reduction in how often the users of GLP-1 drugs (Ozempic or Wegovy being examples) consume alcohol.
Read more...

